# Dingxin Capital

> Dingxin Capital is a VC fund in Beijing backing Medical and Health Care. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 5
- Last investment: Mar 2024
- Lead investor: 40%
- Last updated: Aug 2026
- Website: http://www.dxcapital.com.cn/

Dingxin Capital is a VC fund in Beijing focused on Medical and Health Care. Beijing Dingxin Capital Co., Ltd. is a private equity firm specializing in early and start up stage investments. It prefers to invest in telecommunication, clean technology, new material, advanced manufacturing, healthcare, energy saving, environmental protection, modern agriculture, consumer goods, culture, and modern services industry sectors.Beijing Dingxin Capital Co., Ltd. is based in Beijing, China.

## Contacts

5 contacts available for Dingxin Capital. Shizune tracks 1 team members at Dingxin Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/beijing-dingxin-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 60% |
| Health Care | 3 | 60% |
| Medical Device | 2 | 40% |
| Baby | 1 | 20% |
| Eyewear | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 2 | 40% |
| Series B | 2 | 40% |
| Series D | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 80% |
| United States | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Baozhong Wang | Chairman | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brattea | Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes. |  | Series D | Mar 25, 2024 |  |
| Fine Vision | Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition. | $7.4M | Angel | Jan 31, 2023 |  |
| Hong Jing Drive | Hong Jing Drive is a full-stack autonomous driving solution provider. Automatic driving computing platform, selection and layout of sensors, full-stack software system integration, and calibration for automatic driving. Hong Jing Drive was established on May 2, 2018 by Feilong Liu in Hangzhou, Zhejiang. | $10.2M | Series B | Nov 28, 2022 |  |
| Xingyun Shangcheng | Xingyun Shangcheng is an e-commerce platform that offers a collection of baby products. | $425K | Angel | May 09, 2016 |  |
| Koning | Koning’s vision is to create a revolution in medical imaging through our advanced Computed Tomography technology. Koning’s 3D KBCT produces high-contrast Real 3D images of the breast with exceptional spatial resolution, no painful compression, in a rapid 10-second exposure, at radiation levels in the range of diagnostic mammograms. We believe our3D Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body. Our hope is to be able to improve survival rates and outcomes for millions of patients. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications. | $12M | Series B | Dec 10, 2014 |  |

5 of 5 investments shown.

## Co-investors
- Beijing Fen Xin Investment Management — VC Fund, 1 deal together
- [Bojiang Capital](https://shizune.co/investors/profile/bojiang-capital) — VC Fund, 1 deal together
- [CCB Trust](https://shizune.co/investors/profile/ccb-trust-co) — VC Fund, 1 deal together
- [Guolian Capital](https://shizune.co/investors/profile/guolian-capital) — VC Fund, 1 deal together
- [Jinshi Investment](https://shizune.co/investors/profile/jinshi-investment) — VC Fund, 1 deal together
- [Morning Spring Venture](https://shizune.co/investors/profile/morning-spring-venture) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

## FAQ

### What does Dingxin Capital invest in?

Dingxin Capital invests primarily in Medical, Health Care and Medical Device startups, most often at Angel and Series B stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Dingxin Capital?

Public channels for Dingxin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Dingxin Capital?

The team at Dingxin Capital includes Baozhong Wang (Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co